Global Influenza Treatment Market Size & Outlook

The global influenza treatment market size was estimated at USD 6,005.6 million in 2024 and is projected to reach USD 6,444.8 million by 2030, growing at a CAGR of 1.2% from 2025 to 2030.
Revenue, 2024 (US$M)
$6,005.6
Forecast, 2030 (US$M)
$6,444.8
CAGR, 2025 - 2030
1.2%
Report Coverage
Worldwide

Global influenza treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global influenza treatment market highlights

  • The global influenza treatment market generated a revenue of USD 6,005.6 million in 2024 and is expected to reach USD 6,444.8 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 1.2% by 2030.
  • In terms of segment, oseltamivir phosphate accounted for a revenue of USD 1,678.5 million in 2024.
  • Baloxavir Marboxil is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 6,005.6 million
Market revenue in 2030USD 6,444.8 million
Growth rate1.2% (CAGR from 2025 to 2030)
Largest segmentOseltamivir phosphate
Fastest growing segmentBaloxavir Marboxil
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPeramivira, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate

Other key industry trends

  • In terms of revenue, the North America accounted for 41.5% of the global influenza treatment market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, India is the fastest growing regional market and is projected to reach USD 123.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Influenza Treatment Market Companies

Name Profile # Employees HQ Website
BioCryst Pharmaceuticals Inc View profile 531 4505 Emperor Boulevard, Suite 200, Durham, NC, United States, 27703 https://www.biocryst.com
Daiichi Sankyo Co Ltd View profile 17435 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 https://www.daiichisankyo.com
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
GSK PLC ADR View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Global influenza treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza treatment market will help companies and investors design strategic landscapes.


Oseltamivir phosphate was the largest segment with a revenue share of 27.95% in 2024. Horizon Databook has segmented the Global influenza treatment market based on peramivira, zanamivir, baloxavir marboxil, oseltamivir phosphate covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Influenza Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
    • Peramivira
    • Zanamivir
    • Baloxavir Marboxil
    • Oseltamivir Phosphate
    • Others
  • Global Influenza Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Others
  • Global Influenza Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Reasons to subscribe to Global influenza treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global influenza treatment market databook

  • Our clientele includes a mix of influenza treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global influenza treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global influenza treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global influenza treatment market size, by regions, 2018-2030 (US$M)

Top 10 countries: Influenza treatment market size, 2024 (US$M)

Global influenza treatment market share, by treatment, 2024 & 2030 (%, US$M)

Influenza treatment market: Opportunity assessment by country

Global influenza treatment market, by region, 2024 (US$M)

Global influenza treatment market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online